StemBANCC has assembled a strong multidisciplinary team of top researchers from pharmaceutical companies, research institutions and small and medium enterprises to exploit the rich expertise across sectors and enhance knowledge transfer between academia and industry. The expertise of the team encompasses the range of skills required to deliver a top-notch research program and advance stem cell research for patient benefit. Drawn from different EU member states, cultures and backgrounds all of the members work together towards a common goal.

The Coordinator and Managing entity of StemBANCC are Martin Graf from F. Hoffmann–La Roche Ltd and Dr Zameel Cader from the University of Oxford.